Abstract

BackgroundThe quest to understand the neurobiology of schizophrenia and bipolar disorder is ongoing with multiple lines of evidence indicating abnormalities of glia, mitochondria, and glutamate in both disorders. Despite high heritability estimates of 81% for schizophrenia and 75% for bipolar disorder, compelling links between findings from neurobiological studies, and findings from large-scale genetic analyses, are only beginning to emerge.MethodTen publically available gene sets (pathways) related to glia, mitochondria, and glutamate were tested for association to schizophrenia and bipolar disorder using MAGENTA as the primary analysis method. To determine the robustness of associations, secondary analyses were performed with: ALIGATOR, INRICH, and Set Screen. Data from the Psychiatric Genomics Consortium (PGC) were used for all analyses. There were 1,068,286 SNP-level p-values for schizophrenia (9,394 cases/12,462 controls), and 2,088,878 SNP-level p-values for bipolar disorder (7,481 cases/9,250 controls).ResultsThe Glia-Oligodendrocyte pathway was associated with schizophrenia, after correction for multiple tests, according to primary analysis (MAGENTA p = 0.0005, 75% requirement for individual gene significance) and also achieved nominal levels of significance with INRICH (p = 0.0057) and ALIGATOR (p = 0.022). For bipolar disorder, Set Screen yielded nominally and method-wide significant associations to all three glial pathways, with strongest association to the Glia-Astrocyte pathway (p = 0.002).ConclusionsConsistent with findings of white matter abnormalities in schizophrenia by other methods of study, the Glia-Oligodendrocyte pathway was associated with schizophrenia in our genomic study. These findings suggest that the abnormalities of myelination observed in schizophrenia are at least in part due to inherited factors, contrasted with the alternative of purely environmental causes (e.g. medication effects or lifestyle). While not the primary purpose of our study, our results also highlight the consequential nature of alternative choices regarding pathway analysis, in that results varied somewhat across methods, despite application to identical datasets and pathways.

Highlights

  • The molecular etiologies of schizophrenia and bipolar disorder are not yet understood, hindering efforts to develop novel pharmacological treatments

  • The Glia-Oligodendrocyte pathway was associated with schizophrenia, after correction for multiple tests, according to primary analysis (MAGENTA p = 0.0005, 75% requirement for individual gene significance) and achieved nominal levels of significance with INRICH (p = 0.0057) and ALIGATOR (p = 0.022)

  • Consistent with findings of white matter abnormalities in schizophrenia by other methods of study, the GliaOligodendrocyte pathway was associated with schizophrenia in our genomic study

Read more

Summary

Introduction

The molecular etiologies of schizophrenia and bipolar disorder are not yet understood, hindering efforts to develop novel pharmacological treatments. In order to develop therapeutics for the majority fraction of patients who still do not respond adequately – or at all – to currently available treatments, new insights into the molecular etiology of these and other psychiatric disorders are needed Both schizophrenia and bipolar disorder are known to be highly heritable, with estimates of 81% for schizophrenia and 75% for bipolar disorder [2]. Of great importance regarding the number and distribution of genetic risk factors, polygenic analyses suggest that both disorders are influenced by thousands of risk loci [3] distributed across the genome, and further – that many loci are shared across schizophrenia and bipolar disorder [5] Despite these advances, efforts to understand the biological processes and pathways affected by genetic risk variants are just beginning. Despite high heritability estimates of 81% for schizophrenia and 75% for bipolar disorder, compelling links between findings from neurobiological studies, and findings from large-scale genetic analyses, are only beginning to emerge

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call